Skip to main content
Clinical Trials/NCT00292916
NCT00292916
Terminated
Phase 3

Effect of Whole Body Vibration on Bone and Fall Related Parameters - the Erlangen Longitudinal Vibration Study (ELVIS)

University of Erlangen-Nürnberg Medical School1 site in 1 country150 target enrollmentJanuary 2006
ConditionsAtrophy

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Atrophy
Sponsor
University of Erlangen-Nürnberg Medical School
Enrollment
150
Locations
1
Primary Endpoint
strength
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The effect of whole body vibration (WBV) on bone strength and fall frequency in older adults is still vague. Although there is some evidence that WBV may impact Bone Mineral Density in very frail elderly, there is a lack of data concerning the effect of WBV in community-living elderly woman. We hypothesize that WBV significantly affects bone parameters as assessed by DXA, QCT, US and bone markers with parallel positive changes of fall related risk factors (power, strength, balance, and reaction time). We further hypothesize that the effects of WBV were superior to conventional resistance exercise.

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
July 2007
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Responsible Party
Principal Investigator
Principal Investigator

Wolfgang Kemmler

Principal Investigator

University of Erlangen-Nürnberg Medical School

Eligibility Criteria

Inclusion Criteria

  • community living elderly females \>/=65 years
  • live expectation \> 2 years

Exclusion Criteria

  • secondary osteoporosis
  • CVD-events including stroke
  • participation in other studies
  • medication and illness affecting bone metabolism within the last 2 years
  • medication with impact on falls
  • low physical performance (\<50 Watt during ergometry)
  • excessive alcohol-intake

Outcomes

Primary Outcomes

strength

power

BMD after 6, 12 and 18 months

Secondary Outcomes

  • balance
  • bone markers

Study Sites (1)

Loading locations...

Similar Trials